Experimental study on the effect of Kang-Lai-Te induced apoptosis of human hepatoma carcinoma cell HepG2

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 3, 2009, Pages 267-272

  Lu, Yun ^a   Wu, Li Qun ^a   Dong, Qian ^a   Li, Chang Sheng ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Drugs, Chinese herbal; Fas FasL; Hepatocellular carcinoma; HepG2; Kang Lai Te

Indexed keywords

FAS ANTIGEN; FAS LIGAND; HERBACEOUS AGENT; KANG LAI TE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; COIX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FAS LIGAND PROTEIN; HUMANS; LIVER NEOPLASMS; RNA, MESSENGER; UP-REGULATION;

EID: 67549084680     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Li DP. The anticancer drug Kang-Lai-Te emulsion for infusion. Vestn Ross Akad Med Nauk 2005;32-37. (Pubitemid 41494721)
2. Dong QH, Zhong X, Zheng S. Effect of Kanglaite injection oncyclooxygenase activity in lung carcinoma A549 cell. Zhongguo Zhong Yao Za Zhi 2005;30:1621-1623, 1633. (Pubitemid 44795762)
3. Wu LQ, Lu Y, Lu HJ, Zhao ZG, Yang M. Efficacy of intratumor injection of Kang-Lai-Te in treating transplanted hepatoma in rats. Hepatobiliary Pancreat Dis Int 2004;3:580-584. (Pubitemid 39561971)
4. Qin ZF, Wei PK, Li J. Effect of kanglaite injection combined with Chinese drug therapy according to syndrome differentiation on quality of life and immune function in patients with advanced lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002;22:618-619.
5. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 2006;12:7239-7249. (Pubitemid 44911828)
6. Seet RC, Lau LG, Tambyah PA. Strongyloides hyperinfection and hypogammaglobulinemia. Clin Diagn Lab Immunol 2005;12:680-682. (Pubitemid 41184733)
7. Shimizu Y, Kishimoto T, Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, et al. CCAAT/enhancer binding protein-beta promotes the survival of intravascular rat pancreatic tumor cells via antiapoptotic effects. Cancer Sci 2007;98:1706-1713. (Pubitemid 47487905)
8. Grondin M, Marion M, Denizeau F, Averill-Bates DA. Tributyltin induces apoptotic signaling in hepatocytes through pathways involving the endoplasmic reticulum and mitochondria. Toxicol Appl Pharmacol 2007;222:57-68. (Pubitemid 46978351)
9. Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 2006;43:143-181. (Pubitemid 43860449)
10. Satomi Y, Nishino H, Shibata S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res 2005;25:4043-4047. (Pubitemid 41665183)
11. Kavurma MM, Khachigian LM. Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 2003;10:36-44. (Pubitemid 36511831)
12. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R, Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 1998;282:290-293. (Pubitemid 28487200)
13. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998;187:1205-1213. (Pubitemid 28189110)
14. Li SQ, Liang LJ. Protective mechanism of L-arginine against liver ischemic-reperfusion injury in rats. Hepatobiliary Pancreat Dis Int 2003;2:549-552. (Pubitemid 37441673)
15. He GJ, Yu FQ, Wu R, Gao QY, Xu SH, Gao H, et al. 103Pd-induced apoptosis of proliferative smooth muscle cells in bile ducts of dogs: significance and effects on related genes. Hepatobiliary Pancreat Dis Int 2007;6:521-526. (Pubitemid 47526974)
16. Xiao B, Bi FF, Hu YQ, Tian FF, Wu ZG, Mujlli HM, et al. Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats. Neurotox Res 2007;12:155-162.
17. Tsuzaka K, Matsumoto Y, Sasaki Y, Abe T, Tsubota K, Takeuchi T. Down-regulation of Fas-ligand mRNA in Sjogren's syndrome patients with enlarged exocrine glands. Autoimmunity 2007;40:497-502. (Pubitemid 351233170)
18. Mao H, Liu Q, Zhang J, Gu H, Wang L, Zhou X, et al. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand. Int Immunopharmacol 2007;7:1714-1722. (Pubitemid 350046437)
19. Aoudjehane L, Podevin P, Scatton O, Jaffray P, Dusanter-Fourt I, Feldmann G, et al. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J 2007;21:1433-1444. (Pubitemid 46684846)
20. Li J, Chen X, Dong X, Xu Z, Jiang H, Sun X. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells. J Gastroenterol Hepatol 2006;21:1814-1820. (Pubitemid 44657002)
21. Woo HJ, Park KY, Rhu CH, Lee WH, Choi BT, Kim GY, et al. Beta-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase. J Med Food 2006;9:161-168. (Pubitemid 44036104)
22. Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, et al. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. Int J Oncol 2005;26:1273-1281.